The market value for monoclonal antibodies (mAbs) in colorectal cancer treatment is expected to reach $5.2 billion by 2019. For more information please visit: http://www.marketresearchreports.com/gbi-research/monoclonal-antibodies-market-colorectal-cancer-2019-favorable-pricing-policy-us-and

1. Category : Diseases / Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com

2. Introduction to Report
 Launch Date: December 15, 2013
 Number of Pages:89
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 3,500
Price For Site License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com

3. About the Report
The market value for monoclonal antibodies
(mAbs) in colorectal cancer treatment will
experience a moderate increase from $3.7
billion in 2012 to $5.5 billion by 2019, at a
Compound Annual Growth Rate (CAGR) of 5%.
www.MarketResearchReports.com

4. Scope
A brief introduction to colorectal cancer, including the disease’s
pathogenesis, etiology, diagnosis and treatment algorithms.
In-depth analysis of the three mAbs marketed for colorectal
cancer, including analysis of their safety, efficacy, treatment
patterns and strengths/weaknesses. Including a heat map
comparing the drugs in terms of safety and efficacy.
A comprehensive review of the pipeline for colorectal cancer
therapies, including individual analysis of a number of late-stage
pipeline drugs that are likely to enter the market during the
forecast period. The pipeline is analyzed on the basis of phase
distribution, molecule types, program types, mechanisms of
action and molecular targets.
Additional in-depth analysis of pipeline drug clinical trials by
phase, trial size, trial duration and program failure rate for each
molecule type, in addition to an in-depth analysis of clinical trial
primary endpoints.
www.MarketResearchReports.com

5. Scope
Multi-scenario forecast data of the market to 2019, taking into
account how the market may be affected by the introduction of
new drugs, the expiry of key patents on current drugs and the
changes in disease epidemiology across the key developed
markets.
Discussion of the drivers and barriers for market growth.
In-depth analysis of all licensing and co-development deals that
have occurred in the colorectal cancer market since 2006.
www.MarketResearchReports.com

6. Report Coverage
1. Monoclonal Antibodies in Colorectal Cancer Market to
2019 - Introduction
2. Marketed Products
3. Developmental Pipeline
4. Market Forecast to 2019
5. Deals and Strategic Consolidations
6. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com

7. Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com

8. How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://www.marketresearchreports.com/gbiresearch/monoclonal-antibodies-market-colorectalcancer-2019-favorable-pricing-policy-us-and
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)
www.MarketResearchReports.com